This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnering Summit
May 17-19, 2022
Delivered as a Hybrid EventRevere Hotel Boston Common • Boston, MA

Bruce Hellman
Co-Founder and Chief Patient Officer at uMotif

Profile

Bruce is uMotif’s entrepreneurial leader and co-founded the company in 2012. He and his team have designed and built the uMotif patient-centric data capture platform powering site-based to fully decentralised clinical, real-world, and post-marketing research.

Bruce began his career working in clinical trials at British Biotech before joining the UK Civil Service Fast Stream in the Department for Culture, Media and Sport. Prior to founding uMotif, Bruce was a Management Consultant at Serco and holds an Executive MBA from Imperial College Business School.

Bruce was recognised in the 2019 PharmaVOICE 100 as one of the most innovative entrepreneurs in life sciences and has also been nominated as one of Computer Weekly’s UKtech50 Rising Stars, won the Cisco BIG awards, and was nominated by Real Business magazine as one of the ’30 to watch in mobile’.

Agenda Sessions

  • Putting Rare Disease Patients in the Heart of Clinical Research

    10:15am